Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Convergence 2020 has come and gone, but you can still access recorded sessions, which are available to attendees until 31 December 2020.
Replay the moments of Euro Convergence 2020. Recorded sessions are available to attendees until 31 January 2020.
RAPS' “how to” guide to developing a comprehensive global regulatory strategy for all types of medical devices. Updated September 2020.
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.
Posted 28 August 2012
Australia's Therapeutic Goods Administration (TGA) has released revised guidance on the evidence required to support indications made for over-the-counter (OTC) medicines.
The revised version now permits two ways to provide supporting evidence to the TGA: established sources, such as comprehensive evidence reviews conducted by international regulators (Sources of Established Evidence or "SEE"), or full systematic reviews conducted by the product sponsor where established sources do not exist (Evidence Report).
The new guidance includes essential steps required during the consideration of a SEE, and during the development and fulfillment of the requirements of an Evidence Report. This includes guidance about literature searching, and the assessment of the level, relevance, quality, outcomes and overall balance of currently available evidence.
In recognition of evidence used to support indications for listed medicines is often obtained from the available literature rather than sponsor-initiated clinical trials specifically conducted with a proposed product, a large portion of the guidance is dedicated to providing direction on the assessment of the relevance of scientific and evidence of traditional use to a proposed indication.
Read more
Tags: OTC, medicines, australia, guidance
Regulatory Focus newsletters
All the biggest regulatory news and happenings.